Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion

OBJECTIVE: The predominant mechanism driving hyperuricemia in gout is renal uric acid underexcretion; however, the standard urate‐lowering therapy (ULT) recommendation is first‐line xanthine oxidase inhibitor (XOI), irrespective of the cause of hyperuricemia. This comparative effectiveness clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Fei, Xue, Xiaomei, Lu, Jie, Dalbeth, Nicola, Qi, Han, Yu, Qing, Wang, Can, Sun, Mingshu, Cui, Lingling, Liu, Zhen, He, Yuwei, Yuan, Xuan, Chen, Ying, Cheng, Xiaoyu, Ma, Lidan, Li, Hailong, Ji, Aichang, Hu, Shuhui, Ran, Zijing, Terkeltaub, Robert, Li, Changgui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Gout
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771863/
https://www.ncbi.nlm.nih.gov/pubmed/35795968
http://dx.doi.org/10.1002/art.42266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771863/
https://www.ncbi.nlm.nih.gov/pubmed/35795968
http://dx.doi.org/10.1002/art.42266

Ejemplares similares